COMMUNIQUÉS West-GlobeNewswire

-
Curia Sterile Drug Product Facility Named Massachusetts Manufacturer of the Year
21/10/2025 -
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 42 - 2025
21/10/2025 -
IPSEN - Buy-back programme - Art 5 of MAR - Week 42 - 2025
21/10/2025 -
Cosmos Health Expands Its Ethereum Holdings With an Additional $200,000 Purchase Under Its $300 Million Digital Assets Facility; Total Investment Now Reaches $2 Million
21/10/2025 -
Glo & Spa-rkle Aesthetics and Medspa Celebrates 700-Plus 5-Star Google Reviews, Cementing Rank as Best Laser Tattoo Removal Medspa in Lubbock, Texas.
21/10/2025 -
beyond|AESTHETICS Owner Leslie Petersen, NP, Accepted into Elite Dr. Mauricio de Maio MD Codes™ Fellowship Program
21/10/2025 -
Quercis Pharma and The Galien Foundation to Spotlight Sickle Cell Disease at the 2025 Patient Summit
21/10/2025 -
Glucose Health, Inc. (OTC: GLUC) Announces New Management Appointments and Strategic Outlook
21/10/2025 -
Solenic Medical Announces Successful Use of Its AMF Technology Under FDA Compassionate Use Authorization
21/10/2025 -
AskBio Announces Publication in Nature Medicine of 12-month data from Phase 1 Trial of AB-1002 Gene Therapy in Participants with Congestive Heart Failure
21/10/2025 -
Mineralys Therapeutics Announces Late-Breaking Presentation of Phase 2 Explore-CKD Trial of Lorundrostat at American Society of Nephrology (ASN) Kidney Week 2025
21/10/2025 -
Cidara Therapeutics Announces Late-Breaking Phase 2b Data Presentation on CD388 at ID Week 2025
21/10/2025 -
Ardelyx Announces Four Abstracts Accepted for Poster Presentations at the American Society of Nephrology’s Kidney Week
21/10/2025 -
Medical Specialists of the Palm Beaches Unveils State-of-the-Art Medical Facility in Wellington, Florida
21/10/2025 -
Soleno Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025, at 4:30 PM ET
21/10/2025 -
Avalyn Announces Multiple Presentations at the Pulmonary Fibrosis Foundation (PFF) Summit 2025
21/10/2025 -
Krystal Biotech to Report Third Quarter 2025 Financial Results on November 3, 2025
21/10/2025 -
InnovAge to Announce Fiscal First Quarter 2026 Financial Results and Host Conference Call Tuesday, November 4, 2025
21/10/2025 -
Daxor CEO Michael Feldschuh to Engage Investors at Exclusive Maxim Growth Summit
21/10/2025
Pages